Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · OTC
Our AI ranks Guided Therapeutics Inc outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Guided Therapeutics Inc is a small-cap company with a market capitalization of $18M. It ranks number 24 by market capitalization among the 30 Electromedical & Electrotherapeutic Apparatus issuers in our coverage with a current forecast. Its Current Ratio of 0.09x is the lowest of the 30 peers that report one.
For GTHP, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 28.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 10.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, GTHP included.
Follow GTHP free90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Electromedical & Electrotherapeutic Apparatus peers listed below that report each metric.
| Metric | GTHP | Rank |
|---|---|---|
| Market Cap | $18M | 24/30 |
| EPS | $-0.04 | – |
| Revenue/Share | $0.01 | – |
| Metric | GTHP | Rank |
|---|---|---|
| ROA | -292.0% | 23/24 |
| ROIC | 39.7% | 2/23 |
| Gross Margin | 75.7% | 7/27 |
| Operating Margin | -303.9% | 26/28 |
| Net Margin | -536.9% | 21/22 |
| EBT Margin | -471.2% | 26/28 |
| Tax Rate | 0.0% | – |
| Metric | GTHP | Rank |
|---|---|---|
| Current Ratio | 0.09x | 30/30 |
| Quick Ratio | 0.00x | 29/29 |
| Interest Coverage | -3.5x | 14/30 |
| Working Capital | -$6M | 29/29 |
| Metric | GTHP | Rank |
|---|---|---|
| Operating Cash Flow | -$2M | 15/30 |
| Metric | GTHP | Rank |
|---|---|---|
| Asset Turnover | 0.54x | 11/19 |
| Receivables Turnover | 162.5x | 1/20 |
| Inventory Turnover | 0.3x | 25/27 |
| Fixed Assets Turnover | 59.1x | 4/20 |
| Days Sales Outstanding | 2 days | 20/20 |
| Days Inventory | 1155 days | 3/27 |
| Payables Period | 5422 days | 2/24 |
| Cash Conversion Cycle | -4265 days | 18/19 |
| Metric | GTHP | Rank |
|---|---|---|
| Total Revenue | $650K | 18/19 |
| Operating Income | -$2M | 14/30 |
| Net Income | -$3M | 13/24 |
| R&D Expense | $340K | 27/28 |
| SG&A Expense | $3M | 24/26 |
| Cost of Goods Sold | $160K | 25/27 |
| Metric | GTHP | Rank |
|---|---|---|
| Shares Outstanding | 97M | – |
| Total Current Assets | $530K | |
| Cash & Short-term Investments | $10K | |
| Accounts Receivable | $0.00M | |
| Inventory | $500K | |
| Total Liabilities | $7M | |
| Short-term Debt | $4M |
Companies classified under the same SEC industry code as Guided Therapeutics Inc (Electromedical & Electrotherapeutic Apparatus): 32 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| GTHP Guided Therapeutics Inc | ▲ | $18M |
| MDT Medtronic Plc | ▼ | $121.20B |
| ITGR Integer Holdings Corp | ▼ | $4.31B |
| LIVN Livanova Plc | ▼ | $4.27B |
| TMDX Transmedics Group, Inc. | ▲ | $2.45B |
| BLFS Biolife Solutions Inc | ▶ | $1.89B |
| AXGN Axogen, Inc. | ▲ | $1.86B |
| CNMD Conmed Corp | ▼ | $1.40B |
| CBLL Ceribell, Inc. | ▲ | $961M |
| INMD Inmode Ltd. | ▼ | $814M |
| CV Capsovision, Inc | ▶ | $327M |
| ELMD Electromed, Inc. | ▼ | $229M |
| FOCL Edap Tms Sa | ▲ | $153M |
| VANI Vivani Medical, Inc. | ▶ | $104M |
| STXS Stereotaxis, Inc. | ▶ | $101M |
| NRXS Neuraxis, Inc | ▲ | $97M |
| HYPR Hyperfine, Inc. | ▲ | $75M |
| OM Outset Medical, Inc. | ▲ | $74M |
| ECOR Electrocore, Inc. | ▲ | $71M |
| POSC Positron Corp | ▲ | $51M |
| VASO Vaso Corp | ▲ | $51M |
| POCI Precision Optics Corporation, Inc. | ▲ | $48M |
| QTI Qt Imaging Holdings, Inc. | ▶ | $35M |
| ITOC Itonic Holdings Ltd | ▼ | $28M |
| IRIX Iridex Corp | ▲ | $14M |
| NDRA Endra Life Sciences Inc. | ▶ | $7M |
| ADMT Adm Tronics Unlimited, Inc. | ▶ | $3M |
| NXL Nexalin Technology, Inc. | ▼ | $2M |
| NUWE Nuwellis, Inc. | ▼ | $2M |
| ESMC Escalon Medical Corp | ▲ | $1M |
| HCIL Hongchang International Co., Ltd | ▼ | N/A |
| YBGJ Yubo International Biotech Ltd | ▶ | N/A |
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)-- Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection ...
PEACHTREE CORNERS, Ga., July 22, 2026--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a payment of ...
Guided Therapeutics, Inc. is the maker of a rapid and painless testing platform based on its patented biophotonic technology that utilizes light for the early detection of disease at the cellular ...
Our AI ranks Guided Therapeutics Inc outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
For GTHP, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 28.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 10.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Guided Therapeutics Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
32 issuers in our coverage, GTHP included, share the SEC industry code Electromedical & Electrotherapeutic Apparatus. The largest are: Medtronic Plc (MDT), Integer Holdings Corp (ITGR), Livanova Plc (LIVN), Transmedics Group, Inc. (TMDX), Biolife Solutions Inc (BLFS), Axogen, Inc. (AXGN).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.